Human Exposure to Hantaviruses Associated with Rodents of the Murinae Subfamily, Madagascar
- Resource Type
- Authors
- Ravo Michèle Razafimahefa; Harinirina Aina Rabemananjara; Noël Tordo; Soanandrasana Rahelinirina; Rainer G. Ulrich; Soa Fy Andriamandimby; Jean Théophile Rafisandratantsoa; Claudia Filippone; Christophe Rogier; Judickaelle Irinantenaina; Jean-Michel Heraud; Aina Harimanana; Marie-Marie Olive; Vololoniaina Raharinosy; Sandra Telfer; Minoarisoa Rajerison; Jean Pierre Ravalohery; Jean Marc Reynes; Stéphane Petres
- Source
- Emerging Infectious Diseases
Emerging Infectious Diseases, Centers for Disease Control and Prevention, 2020, 26 (3), pp.587-590. ⟨10.3201/eid2603.190320⟩
Emerging Infectious Diseases, 2020, 26 (3), pp.587-590. ⟨10.3201/eid2603.190320⟩
Emerging Infectious Diseases, Vol 26, Iss 3, Pp 587-590 (2020)
- Subject
- Male
Subfamily
Epidemiology
lcsh:Medicine
hantavirus
Serology
Mice
0302 clinical medicine
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Zoonoses
Prevalence
030212 general & internal medicine
Child
Aged, 80 and over
biology
seroprevalence
Dispatch
human population
Middle Aged
3. Good health
Infectious Diseases
rodents
Child, Preschool
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Female
Microbiology (medical)
Adult
Adolescent
Hantavirus Infections
030231 tropical medicine
Commercial kit
Virus
lcsh:Infectious and parasitic diseases
03 medical and health sciences
Young Adult
Human Exposure to Hantaviruses Associated with Rodents of the Murinae Subfamily, Madagascar
Madagascar
Seroprevalence
Animals
Humans
lcsh:RC109-216
viruses
Hantavirus
Aged
Disease Reservoirs
Retrospective Studies
lcsh:R
Murinae
biology.organism_classification
Virology
[SDE.ES]Environmental Sciences/Environmental and Society
Human exposure
[SDE.BE]Environmental Sciences/Biodiversity and Ecology
- Language
- English
- ISSN
- 1080-6059
1080-6040
International audience; We conducted a national human serologic study of a hantavirus detected in Madagascar rodents using a commercial kit and a new ELISA targeting the virus. Our results suggest a conservative estimate of 2.7% (46/1,680) IgG seroprevalence. A second single-district study using the new ELISA revealed a higher prevalence (7.2%; 10/139).